Anthony S. Gibney

Business address
C/O Achillion Pharmaceuticals, Inc., 300 George Street, New Haven, CT, 06511
Top holdings (ownership)
AURA and CLSD
Get insider transactions for this reporting owner
Anthony S. Gibney has filed 19 SEC EDGAR filings since 16 Aug 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 04 Jun 2025 02 Jun 2025 001-40971
4 Open Document Open Filing 4 20 May 2025 16 May 2025 001-40971
144 Open Document Open Filing 16 May 2025
3 Open Document Open Filing 3 16 May 2025 13 May 2025 001-40971
4 Open Document Open Filing 21 Jun 2024 20 Jun 2024 001-37783
4 Open Document Open Filing 19 Apr 2024 17 Apr 2024 001-37783
4 Open Document Open Filing 16 Apr 2024 15 Apr 2024 001-37783
3 Open Document Open Filing 16 Apr 2024 15 Apr 2024 001-37783
4 Open Document Open Filing OWNERSHIP DOCUMENT 13 Jul 2023 11 Jul 2023 001-36080
4 Open Document Open Filing FORM 4 30 Jun 2023 28 Jun 2023 001-36080
4 Open Document Open Filing FORM 4 22 Dec 2022 20 Dec 2022 001-36080
4 Open Document Open Filing FORM 4 14 Dec 2022 13 Dec 2022 001-36080
4 Open Document Open Filing FORM 4 05 Jul 2022 30 Jun 2022 001-36080
4 Open Document Open Filing OWNERSHIP DOCUMENT 15 Dec 2021 13 Dec 2021 001-36080
3 Open Document Open Filing OWNERSHIP DOCUMENT 15 Dec 2021 13 Dec 2021 001-36080
4 Open Document Open Filing PRIMARY DOCUMENT 29 Jan 2020 28 Jan 2020 001-33095
4 Open Document Open Filing FORM 4 SUBMISSION 25 Jan 2019 23 Jan 2019 001-33095
4 Open Document Open Filing FORM 4 SUBMISSION 16 Aug 2018 15 Aug 2018 001-33095
3 Open Document Open Filing FORM 3 SUBMISSION 16 Aug 2018 15 Aug 2018 001-33095